Science World ReportRx Improved Stem Cell Transplant Success and SurvivaldailyRxVelcade lowered GVHD and improved survival of stem cell transplant patients. Share on Facebook. Print. December 8, 2013. (dailyRx News) To avoid potentially lethal complica…
Boston Globe |
HIV returns in 2 thought cured after stem cell transplant
Bangor Daily News GENEVA — Two HIV-infected men who were thought to be clear of the virus after having stem cell transplants have had the AIDS-causing pathogen return, their doctors said, dashing hopes that their cases might lead to a cure. The two Boston men, who were … HIV returns in two patients after bone marrow transplantCNN |
The Canberra Times |
Nurse Kerri Cargill’s wait for life-saving organ donor reveals patchwork of …
The Canberra Times The Organ and Tissue Authority says less than 1 per cent of people die in intensive care units or emergency departments in the specific circumstances required to be a potential organ donor. It says it is vital that potential donor families realise that … |
|
New Drug Combo Potentially ‘Practice Changing’ in CLL
Medscape NEW ORLEANS — More clinical details have been reported showing how the new monoclonal antibody obinutuzumab (Gazvya, Roche) was superior to the stadard therapy rituximab (Rituxan, Roche) when both were used in combination with chlorambucil in … |
Gilead Announces Pivotal Phase 2 Data for Idelalisib in Refractory Indolent …Business Wire (press release)Study 101-09 is a Phase 2, open-label, single-arm efficacy and safety study of idelalisib in patients with previously treated iNHL that is refra…
NPRHIV returns in 2 thought cured after stem cell transplantThe ColumbianGENEVA – Two HIV-infected men who were thought to be clear of the virus after having stem cell transplants have had the AIDS-causing pathogen return, their doctors said, dashing h…
WalesOnline |
Dr. Goede on Obinutuzumab Versus Rituximab in CLL
OncLive Valentin Goede, MD, from the University Hospital Cologne and the German CLL Study Group, discusses the efficacy findings from the stage 2 CLL11 study that examined obinutuzumab (Gazyva; formally GA101) plus chlorambucil in patients with chronic … New Drug Combo Potentially ‘Practice Changing’ in CLLMedscape Improved Efficacy, Limited Toxicity of Targeted Therapies Brighten the Future …SYS-CON Media (press release) ‘Exciting’ leukaemia drug trial results published after Welsh hospital trialsWalesOnline |
|
Excitement Over CAR-Engineered T-cells in Leukemia and Lymphoma
Medscape This was a patient who had undergone 10 prior therapies, including many different combinations of rituximab plus chemotherapy regimens, and the disease progressed a month after chemotherapy finished, so she was “clearly refractory,” he said. “Our data … Treated T-cells induce remissions in chemo-refractory B-cell lymphomasThe Oncology Report |
|
Tracking your heart while you pound the road
Times of India “This is the first of its kind not only in India but in the world. It is already out in the market. The device is attached to the athlete’s body. We are going to work on a sports module for the same machine that is attached to the body now. It will be … |
The Nation |
HIV returns in 2 thought cured after stem cell transplant
Chicago Tribune HIV returns in 2 thought cured after stem cell transplant. print. By Simeon Bennett, Bloomberg News Bloomberg. 11:20 p.m. CST, December 8, 2013. GENEVA — Two HIV-infected men who were thought to be clear of the virus after having stem cell transplants … HIV Returns in Two Men Thought Cured After Stem Cell TransplantBusinessweek HIV returns in two patients after bone marrow transplantksl.com |